Lisanti Capital Growth LLC Invests $2.80 Million in Amprius Technologies, Inc. $AMPX

Lisanti Capital Growth LLC purchased a new position in Amprius Technologies, Inc. (NYSE:AMPX) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 265,725 shares of the company’s stock, valued at approximately $2,795,000.

A number of other large investors also recently bought and sold shares of AMPX. Bank of America Corp DE grew its holdings in Amprius Technologies by 31.1% in the fourth quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after purchasing an additional 3,055 shares during the period. Ameritas Investment Partners Inc. boosted its position in shares of Amprius Technologies by 2,043.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 9,516 shares of the company’s stock worth $40,000 after purchasing an additional 9,072 shares in the last quarter. Rhumbline Advisers boosted its position in shares of Amprius Technologies by 61.1% in the 1st quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock worth $42,000 after purchasing an additional 5,951 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Amprius Technologies by 1,385.4% in the 2nd quarter. Legal & General Group Plc now owns 10,383 shares of the company’s stock worth $44,000 after buying an additional 9,684 shares during the last quarter. Finally, XTX Topco Ltd bought a new position in Amprius Technologies during the 2nd quarter valued at approximately $44,000. 5.04% of the stock is owned by hedge funds and other institutional investors.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Needham initiated coverage with a Buy and a $20 price target (roughly +61% upside from current levels), a bullish analyst catalyst that likely drew buyer interest and helped fuel recent gains. Needham initiates coverage of Amprius
• Positive Sentiment: MarketBeat highlighted Amprius’ expanding production capacity and new South Korean manufacturing partners, noting the company is ahead of plan and positioning for an improved path to profitability ahead of FY2025 Q4 results (late March) — a concrete operational improvement that supports longer‑term upside. 5 Stocks to Buy in February: Last Year’s Winners Aren’t Done Yet (AMPX)
• Positive Sentiment: Unusual options activity: a large purchase of call options (22,391 contracts) suggests elevated bullish/speculative interest and short‑term upside betting by traders — this can amplify intraday moves and volatility.
• Neutral Sentiment: Several outlets ran takeaways asking whether recent multi‑month gains make AMPX “too late” to buy and examining valuation after a big run; these pieces increase retail attention but don’t settle fundamentals one way or the other. Is It Too Late To Consider Buying Amprius Technologies (AMPX)
• Negative Sentiment: Zacks noted a recent sharp intraday gain but flagged that the trend in earnings‑estimate revisions does not support sustained upside — a warning that analysts’ expectations may not be accelerating enough to justify the rally. Amprius (AMPX) Moves 13.4% Higher: Will This Strength Last?
• Negative Sentiment: Fundamental risk: Amprius still shows negative net margin and negative ROE and trades with a high beta — meaning the stock is sensitive to sentiment swings and could face profit‑taking or re‑rating if upcoming earnings fail to show clear progress toward profitability.

Insider Buying and Selling

In other Amprius Technologies news, Director Kang Sun sold 43,185 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $11.03, for a total transaction of $476,330.55. Following the completion of the sale, the director directly owned 1,403,651 shares in the company, valued at approximately $15,482,270.53. The trade was a 2.98% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Constantin Ionel Stefan sold 39,690 shares of the firm’s stock in a transaction on Wednesday, January 28th. The stock was sold at an average price of $12.00, for a total value of $476,280.00. Following the completion of the transaction, the chief technology officer owned 748,696 shares in the company, valued at approximately $8,984,352. This trade represents a 5.03% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 3,399,331 shares of company stock valued at $37,048,615. 12.90% of the stock is currently owned by insiders.

Amprius Technologies Stock Performance

Shares of NYSE:AMPX opened at $12.42 on Friday. The firm has a market cap of $1.62 billion, a price-to-earnings ratio of -47.77 and a beta of 3.04. The business has a 50-day simple moving average of $10.27 and a two-hundred day simple moving average of $10.02. Amprius Technologies, Inc. has a fifty-two week low of $1.70 and a fifty-two week high of $16.03.

Amprius Technologies (NYSE:AMPX) last announced its quarterly earnings results on Thursday, November 6th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. Amprius Technologies had a negative net margin of 53.16% and a negative return on equity of 38.85%. The firm had revenue of $21.43 million during the quarter, compared to analyst estimates of $16.45 million. As a group, research analysts predict that Amprius Technologies, Inc. will post -0.45 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Cantor Fitzgerald lifted their price target on Amprius Technologies from $12.00 to $16.00 and gave the stock an “overweight” rating in a research report on Friday, November 7th. Northland Securities set a $20.00 price objective on shares of Amprius Technologies in a research note on Tuesday, October 7th. Needham & Company LLC began coverage on shares of Amprius Technologies in a research note on Thursday. They issued a “buy” rating and a $20.00 target price on the stock. Roth Mkm set a $14.00 price target on shares of Amprius Technologies and gave the company a “buy” rating in a report on Wednesday, October 22nd. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Amprius Technologies in a research report on Wednesday, January 21st. Seven investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $16.57.

Amprius Technologies Company Profile

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.